Immunovant, Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Dec 20, 2019 FORM 4 SUBMISSION
4 Dec 20, 2019 FORM 4 SUBMISSION
4 Dec 20, 2019 FORM 4 SUBMISSION
4 Dec 20, 2019 FORM 4 SUBMISSION
4 Dec 20, 2019 FORM 4 SUBMISSION
4 Dec 20, 2019 FORM 4 SUBMISSION
4 Dec 20, 2019 FORM 4 SUBMISSION
4 Dec 20, 2019 FORM 4 SUBMISSION
4 Dec 20, 2019 FORM 4 SUBMISSION
3 Dec 20, 2019 FORM 3 SUBMISSION
3 Dec 20, 2019 FORM 3 SUBMISSION
3 Dec 20, 2019 FORM 3 SUBMISSION
3 Dec 20, 2019 FORM 3 SUBMISSION
3 Dec 20, 2019 FORM 3 SUBMISSION
3 Dec 20, 2019 FORM 3 SUBMISSION
3 Dec 20, 2019 FORM 3 SUBMISSION
3 Dec 20, 2019 FORM 3 SUBMISSION
3 Dec 20, 2019 FORM 3 SUBMISSION
3 Dec 20, 2019 FORM 3 SUBMISSION
4 Dec 20, 2019 OWNERSHIP DOCUMENT
8-K Dec 17, 2019 CURRENT REPORT
4 Dec 13, 2019 OWNERSHIP DOCUMENT
DEFA14A Dec 13, 2019 DEFINITIVE ADDITIONAL MATERIALS
4 Dec 10, 2019
4 Dec 9, 2019
← Newer Page 23 of 26 · 646 filings Older →